Profiles

Naama Karu

UTAS Home Dr Naama Karu
Naama Karu

Naama Karu

Postdoctoral Research Fellow

Room 401, Chemistry Building, Sandy Bay Campus

+61 3 6226 1074 (phone)

+61 3 6226 2858 (fax)

Naama.Karu@utas.edu.au

View more on Dr Naama Karu in WARP

Research Fields

  • Separation Science (030108)
  • Nephrology and Urology (110312)
  • Cell Metabolism (060104)
  • Clinical Sciences (110399)
  • Medical Biochemistry and Metabolomics (110199)
  • Aboriginal and Torres Strait Islander Health (111701)
  • Zoology (060899)

Research Impact

  • Expanding Knowledge in the Chemical Sciences (970103)
  • Human Pharmaceutical Products (860899)
  • Aboriginal and Torres Strait Islander Health - Health Status and Outcomes (920302)
  • Urogenital System and Disorders (920119)
  • Aboriginal and Torres Strait Islander Health - Determinants of Health (920301)
  • Diagnostic Methods (920203)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
  • Expanding Knowledge in the Biological Sciences (970106)

Publications

Total publications

10

Journal Article

(6 outputs)
YearCitationAltmetrics
2015Oliver JD, Sutton AT, Karu N, Phillips M, Markham J, et al., 'Simple and robust monitoring of ethanol fermentations by capillary electrophoresis', Biotechnology and Applied Biochemistry, 62, (3) pp. 329-342. ISSN 0885-4513 (2015) [Refereed Article]

DOI: 10.1002/bab.1269 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Hilder EF

Tweet

2012Karu N, Dicinoski GW, Haddad PR, 'Use of suppressors for signal enhancement of weakly-acidic analytes in ion chromatography with universal detection methods', TrAC Trends in Analytical Chemistry, 40 pp. 119-132. ISSN 0165-9936 (2012) [Refereed Article]

DOI: 10.1016/j.trac.2012.07.019 [eCite] [Details]

Citations: Scopus - 6Web of Science - 7

Co-authors: Dicinoski GW; Haddad PR

Tweet

2012Karu N, Dicinoski GW, Hanna-Brown M, Haddad PR, 'Determination of pharmaceutically related compounds by suppressed ion chromatography: II. Interactions of analytes with the suppressor', Journal of Chromatography A, 1224, (1) pp. 35-42. ISSN 0021-9673 (2012) [Refereed Article]

DOI: 10.1016/j.chroma.2011.12.022 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Dicinoski GW; Haddad PR

Tweet

2012Karu N, Dicinoski GW, Hanna-Brown M, Srinivasan K, Pohl CA, et al., 'Determination of pharmaceutically related compounds by suppressed ion chromatography: III. Role of electrolytic suppressor design', Journal of Chromatography A, 1233 pp. 71-77. ISSN 0021-9673 (2012) [Refereed Article]

DOI: 10.1016/j.chroma.2012.02.008 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Dicinoski GW; Haddad PR

Tweet

2012Karu N, Hutchinson JP, Dicinoski GW, Hanna-Brown M, Srinivasan K, et al., 'Determination of pharmaceutically related compounds by suppressed ion chromatography: IV. Interfacing ion chromatography with universal detectors', The Journal of Chromatography A, 1253 pp. 44-51. ISSN 0021-9673 (2012) [Refereed Article]

DOI: 10.1016/j.chroma.2012.06.101 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: Hutchinson JP; Dicinoski GW; Haddad PR

Tweet

2011Karu N, Dicinoski GW, Hanna-Brown M, Haddad PR, 'Determination of pharmaceutically related compounds by suppressed ion chromatography: I. Effects of organic solvent on suppressor performance', Journal of Chromatography A, 1218, (50) pp. 9037-9045. ISSN 0021-9673 (2011) [Refereed Article]

DOI: 10.1016/j.chroma.2011.10.011 [eCite] [Details]

Citations: Scopus - 11Web of Science - 9

Co-authors: Dicinoski GW; Haddad PR

Tweet

Conference Publication

(4 outputs)
YearCitationAltmetrics
2016Karu N, McKercher CM, Nichols DS, Davies NW, Wilson RR, et al., 'From non-targeted metabolomics to quantitative analysis of uremic compounds in chronic kidney disease', Proceedings of The Australian & New Zealand Metabolomics Conference, 31st March - 1st April, 2016, Melbourne, Australia (2016) [Conference Extract]

[eCite] [Details]

Co-authors: McKercher CM; Nichols DS; Davies NW; Wilson RR; Hilder EF; Shellie RA; Jose MD

2016Karu N, Wilson RR, Hamede Ross RK, Jones Menna, Woods GM, et al., 'Discovery of serum biomarkers for Tasmanian Devil cancer (DFTD)', Proceedings of The Australian & New Zealand Metabolomics Conference, 31st March - 1st April, 2016, Melbourne, Australia (2016) [Conference Extract]

[eCite] [Details]

Co-authors: Wilson RR; Hamede Ross RK; Jones Menna; Woods GM; Hilder EF; Shellie RA

2015Jose MD, Karu N, McKercher CM, Nichols DS, Davies NW, et al., 'Tryptophan metabolism in chronic kidney disease is related to the inflammation marker neopterin and to neuropsychological measures', ANZSN 51st Annual Scientific Meeting 2015, 7-9 September, 2015, Canberra, Australia (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Jose MD; McKercher CM; Nichols DS; Davies NW; Shellie RA; Hilder EF

2013Karu N, Davies NW, Wilson RR, Shellie RA, Thompson RS, et al., 'Mass spectrometry for the determination of renal disease biomarkers in urine', Proceedings of the 24th meeting of the Australian and New Zealand Society for Mass Spectrometry, 2-6 February 2013, Melbourne, Australia (2013) [Conference Extract]

[eCite] [Details]

Co-authors: Davies NW; Wilson RR; Shellie RA; McMorran BJ; Jose MD; Foote SJ; Hilder EF

Grants & Funding

Funding Summary

Number of grants

2

Total funding

$55,727

Projects

Metabolomics for Tasmanian devil DFTD biomarkers discovery (2015)$33,000
Description
The project aims to create a databank of metabolic profiles from 100 Tasmanian devil serum samples using high-resolution instrumentation and then probe this databank to unravel the metabolic differences between healthy and DFTD animals.
Funding
University of Tasmania Foundation Inc ($33,000)
Scheme
Grant-Dr Eric Guiler Tasmanian Devil Research Gran
Administered By
University of Tasmania
Research Team
Shellie RA; Karu N; Wilson RR; Hamede Ross RK; Hilder EF
Year
2015
Towards a better understanding of uraemic molecules (2013)$22,727
Funding
Royal Hobart Hospital Research Foundation ($22,727)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Jose MD; Hilder EF; Shellie RA; Karu N
Year
2013